Arcadia Biosciences, Inc (RKDA) Fair Value & Analysis
Consumer Defensive · US · Market cap $1.5M
Fair value as of: Jun 25, 2026
Analysis
Arcadia Biosciences, Inc (RKDA) currently trades at $0.6705, while our model-based Fair Value estimate is $1.92 — implying the stock looks roughly 186.4% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Arcadia Biosciences, Inc (RKDA) undervalued?
What is the fair value of RKDA?
What is the quality score of RKDA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.